Answers are grounded in this paper and cite their sources.
Screening and early detection of hyperglycemia are among the cornerstones in the recent Standards of Medical Care in Diabetes—2017 published by the American Diabetes Association (ADA) (1), despite the debate as to their overall benefits (2,3). In fact, this year new tools have been added to the bag: an “ADA risk test” (4) to screen for intermediate hyperglycemia (designated “prediabetes” by the ADA) and type 2 diabetes (T2D). If intermediate hyperglycemia is identified, then at least annual monitoring for the development of T2D is recommended. The risk evaluation is based on an online questionnaire in which a person’s risk is calculated on the basis of age, sex, family history of T2D, activity level, and weight. Unfortunately, this strategy overestimates the risk and leads to unnecessary worries and …
No takes yet. Share an insight, caveat, or question.
Sonne et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: